We are live on
!
Find out more
CM
Corvex Management Portfolio holdings
AUM
$3.27B
1-Year Est. Return
38.53%
This Fund
S&P 500
This Quarter
Est. Return
+6.22%
1 Year Est. Return
+38.53%
3 Year Est. Return
+95.78%
5 Year Est. Return
+93.81%
10 Year Est. Return
+360.33%
AUM
$7.51B
AUM Growth
+$1.45B
(+24%)
Cap. Flow
-$391M
Cap. Flow
% of AUM
-5.21%
Top 10 Holdings %
Top 10 Hldgs %
80.66%
Holding
39
New
18
Increased
6
Reduced
3
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAV
B/E Aerospace Inc
BEAV
|
+$129M |
| 2 |
Johnson Controls International
JCI
|
+$113M |
| 3 |
Signet Jewelers
SIG
|
+$90.4M |
| 4 |
MON
Monsanto Co
MON
|
+$73.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$69.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$520M |
| 2 |
VER
VEREIT, Inc.
VER
|
+$315M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 4 |
EQC
Equity Commonwealth
EQC
|
+$111M |
| 5 |
Bausch Health
BHC
|
+$52.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 34.06% |
| 2 | Miscellaneous | 23.94% |
| 3 | Energy | 12.3% |
| 4 | Financials | 9.4% |
| 5 | Healthcare | 4.62% |
Similar funds
ADEF
FB
CAMG
SCM
VVP
BG
OCM
PCM
Corvex Management's Q2 2016 Portfolio in Review
As of Q2 2016, Corvex Management held 39 positions worth $7.51B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Corvex Management withdrew a net $391M in Q2 2016, closing 5 positions and reducing 3 holdings. Its most notable exit was Pfizer, an estimated $520M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, down from 44% a quarter earlier, followed by Miscellaneous and Energy.
Against the trend, Corvex Management opened a new position in B/E Aerospace Inc worth $125M.
- Corvex Management's largest Q2 2016 buy was B/E Aerospace Inc: 2,703,259 shares worth $125M.
- Corvex Management added most to Signet Jewelers in Q2 2016, an estimated $90.4M increase.
- Corvex Management's biggest Q2 2016 reduction was VEREIT, Inc., cutting an estimated $315M.
- Corvex Management fully exited Pfizer in Q2 2016, selling an estimated $520M.
- Corvex Management's ten largest holdings make up 81% of its $7.51B portfolio in Q2 2016.
- Corvex Management opened 18 new positions and closed 5 in Q2 2016.
- Corvex Management's portfolio value rose 24% quarter-over-quarter to $7.51B.
Based on Corvex Management's 13F filing for Q2 2016, filed 15 Aug 2016.